SCHEMBL6906465

SCHEMBL6906465

[C-]#[N+]c1cc(C)ccc1[N+](=O)[O-]

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.60
CYP3A4 P08684 2/20 0.60
KAT2B Q92831 3/20 0.44
GPR35 Q9HC97 2/20 0.41
ACHE P22303 2/20 0.41
HSD17B10 Q99714 2/20 0.41
TDP1 Q9NUW8 2/20 0.40
ATM Q13315 1/20 0.40
MAPT P10636 2/20 0.40
ABCC3 O15438 1/20 0.40
ABCC4 O15439 1/20 0.40
NR1I2 O75469 1/20 0.40
ABCB11 O95342 1/20 0.40
TTR P02766 1/20 0.40
NR3C1 P04150 1/20 0.40
PGR P06401 1/20 0.40
HTR1A P08908 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
RARB P10826 1/20 0.40
COMT P21964 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8134347 0.85 TSHR (0.60) TSHRCYP3A4KAT2BGPR35ACHE
SCHEMBL18412395 0.81 TSHR (0.60) TSHRCYP3A4KAT2BGPR35ACHE
SCHEMBL29950638 0.76 HSD17B10 (0.48) TSHRGPR35HSD17B10TDP1ALDH1A1
SCHEMBL2722562 0.76 HSD17B10 (0.48) TSHRGPR35HSD17B10TDP1ALDH1A1
SCHEMBL294724 0.76 TSHR (1.00) TSHRCYP3A4KAT2BGPR35ACHE
SCHEMBL29384695 0.75 TSHR (0.67) TSHRCYP3A4KAT2BGPR35ACHE
SCHEMBL247992 0.75 TSHR (0.67) TSHRCYP3A4KAT2BGPR35ACHE
SCHEMBL29953061 0.74 TDP1 (0.64) TSHRCYP3A4GPR35HSD17B10TDP1
SCHEMBL10966954 0.74 TDP1 (0.64) TSHRCYP3A4GPR35HSD17B10TDP1
SCHEMBL557939 0.74 TSHR (0.72) TSHRCYP3A4KAT2BGPR35ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8541404-B2 Inhibitors of the human aldosterone synthase CYP11B2 ELEXOPHARM GMBH (DE) 2013-09-24 US disclosed
US-20110118241-A1 6-Pyridin-3-YL-3,4-Dihydro-1H-Quinolin-2-One Derivatives and Related Compounds as Inhibitors of the Human Aldosterone Synthase CYP11B2 UNIVERSITAT DES SAARLANDES (DE) 2011-05-19 US disclosed
US-20110112067-A1 Inhibitors of the Human Aldosterone Sythase CYP11B2 UNIVERSITAT DES SAARLANDES (DE) 2011-05-12 US disclosed
US-20100260825-A1 Antifolates for the treatment of cardiovascular, inflammatory, neoplastic, autoimmune and related diseases in sublingual dosage units, film strips, or skin patches NAIR MADHAVAN G 2010-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118241-A1 6-Pyridin-3-YL-3,4-Dihydro-1H-Quinolin-2-One Derivatives and Related Compounds as Inhibitors of the Human Aldosterone Synthase CYP11B2 HSD11B1, HSD11B2, CYP4A11 TSHR 3268/4885CYP3A4 77/4885KAT2B 3907/4885
US-20100260825-A1 Antifolates for the treatment of cardiovascular, inflammatory, neoplastic, autoimmune and related diseases in sublingual dosage units, film strips, or skin patches SLC19A1, TPMT, DHFR TSHR 354/4885CYP3A4 84/4885KAT2B 2719/4885
US-20110112067-A1 Inhibitors of the Human Aldosterone Sythase CYP11B2 HSD11B1, HSD11B2, CYP11B1 TSHR 3029/4885CYP3A4 477/4885KAT2B 2859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.